Rottinghaus Scott T.
Chief Medical Officer at ENTA
- Sold, on record
- $214k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Dec 5, 2025
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ENTAENANTA PHARMACEUTICALS INCChief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ENTANo planDec 5, 2023 2023
Sold 534 shares at $9.63 ($5k)
Rottinghaus Scott T., Sr. VP & CMO
No 10b5-1 planSold 2% of holdings ($260k position)26,466 shares leftFirst sale on recordFiling
- 2 Form 144 notice ENTANoticeJul 11, 2024 +219 days
Filed to sell 11,945 shares ($179k)
Rottinghaus Scott T., Officer
10b5-1 planFiling
- 3 Form 4 sale ENTARoutineJul 15, 2024 +4 days
Sold 11,945 shares at $15.97 ($191k)
Rottinghaus Scott T., Chief Medical Officer
10b5-1 planSold 35.5% of holdings ($538k position)21,717 shares leftFollows a Form 144Filing
- 4 Form 4 sale ENTARoutineDec 6, 2024 +144 days
Sold 866 shares at $8.06 ($7k)
Rottinghaus Scott T., Chief Medical Officer
10b5-1 planSold 4.6% of holdings ($151k position)17,918 shares leftFiling
- 5 Form 4 sale ENTANo planDec 5, 2025 +364 days
Sold 798 shares at $14.23 ($11k)
Rottinghaus Scott T., Chief Medical Officer
No 10b5-1 planSold 3.5% of holdings ($321k position)21,792 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | Dec 5, 2025 | ENTA | Chief Medical Officer | Form 4 sale | 798 | $11k | 3.5% | No plan | SEC |
| Dec 6, 2024 | Dec 10, 2024 | ENTA | Chief Medical Officer | Form 4 sale | 866 | $7k | 4.6% | Routine | SEC |
| Jul 15, 2024 | Jul 15, 2024 | ENTA | Chief Medical Officer | Form 4 sale | 11,945 | $191k | 35.5% | Routine | SEC |
| Jul 11, 2024 | Jul 11, 2024 | ENTA | Officer | Form 144 notice | 11,945 | $179k | Notice | SEC | |
| Dec 5, 2023 | Dec 6, 2023 | ENTA | Sr. VP & CMO | Form 4 sale | 534 | $5k | 2.0% | No plan | SEC |